[1]
Chen, Q.X.; Kubo, I.J. Kinetics of mushroom tyrosinase inhibition by quercetin. J. Agric. Food Chem., 2002, 50, 4108-4112.
[2]
Maeda, K.; Fukuda, M.J. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J. Pharmacol. Exp. Ther., 1996, 276(2), 765-769.
[3]
Matsuura, R.; Ukeda, H.; Sawamura, M.J. Tyrosinase inhibitory activity of citrus essential oil. J. Agric. Food Chem., 2006, 54(6), 22309-22313.
[4]
Nihei, K.; Kubo, I. Identification of oxidation product of arbutin in mushroom tyrosinase assay system. Bioorg. Med. Chem. Lett., 2003, 13, 2409.
[5]
Seo, S.Y.; Sharma, V.K.; Sharma, N.J. Mushroom tyrosinase: Recent prospects. J. Agric. Food Chem., 2003, 51, 2837-2853.
[6]
Tsuji-Naito, K.; Hatani, T.; Okada, T.; Tehara, T. Modulating effects of a novel skinlightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products. Bioorg. Med. Chem., 2007, 15, 1967-1975.
[7]
Maeda, L.; Yoshizaki, K. Intestinal term pregnancy without rupture. Nippon Sanka Fujinka Gakkai Zasshi, 1991, 43, 361-363.
[8]
Paul, M.; Jennifer, R. Radiative relaxation quantum yields for synthetic eumelanin. Photochem. Photobiol., 2007, 79, 211-216.
[9]
Vandamme, M. Antitumor effect of plasma treatment on u87 glioma xenografts: Preliminary results. Plasma Process. Polym., 2010, 7, 264-273.
[10]
Cooksey, C.J.; Garratt, P.J.; Land, E.J.; Pavel, S.; Ramsden, C.A.; Riley, P.A.; Smit, N.P. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. Biol. Chem., 1997, 272, 29226-29235.
[11]
Hearing, V.J.; Jimenez, M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res., 1989, 2, 75-85.
[12]
Fairhead, M.; Thony-Meyer, L.N. Bacterial tyrosinase: Old enzymes with new relevance to biotechnology. Biotechnol., 2012, 29, 183-191.
[13]
Cordes, P.; Sun, W.; Wolber, R.; Kolbe, L.; Klebe, G.; Ro¨hm, K.H. Expression in nonmelanogenic systems and purification of soluble variants of human tyrosinase. Biol. Chem., 2013, 394, 685-693.
[14]
Fogal, S.; Carotti, M.; Giaretta, L.; Lanciai, F.; Nogara, L.; Bubacco, L.; Bergantino, E. Human tyrosinase produced in insect cells: A landmark for the screening of new drugs addressing its activity. Mol. Biotechnol., 2015, 57, 45-57.
[15]
Lai, X.; Soler-Lopez, M.; Wichers, H.J.; Dijkstra, B.W. Large-scale recombinant expression and purification of human tyrosinase suitable for structural studies. PLoS One, 2016, 110161697
[16]
Garcia-Molina, F.; Hiner, A.N.; Fenoll, L.G.; Rodriguez-Lopez, J.N.; Garcia-Ruiz, P.A.; Garcia-Canovas, F. Mushroom tyrosinase: Catalase activity, inhibition, and suicide inactivation. J. Agric. Food Chem., 2005, 53, 3702-3709.
[17]
Buyukokuroglu, M.E. Gulçİn, İ.; Oktay, M.; Küfrevİoğlu, Ö.İ. In vitro antioxidant properties of dantrolene sodium. Pharmacol. Res., 2001, 44, 491-494.
[18]
Shahidi, F.; Janitha, P.K.; Wanasundara, P.D. Phenolic antioxidants. Crit. Rev. Food Sci. Nutr., 1992, 32, 67-103.
[19]
Gülçin, İ.; Oktay, M.; Küfrevioğlu, Ö.İ.; Aslan, A.J. Determination of antioxidant activity of lichen Cetraria islandica (L) Ach. J. Ethnopharmacol., 2002, 79, 325-329.
[20]
Yasui, H.; Sakurai, H. Age-dependent generation of reactive oxygen species in the skin of live hairless rats exposed to UVA light. Exp. Dermatol., 2003, 12, 655-661.
[21]
Garcia, A.; Fulton, J.E., Jr The combination of glycolic acid and hydroxyquinone or kojic acid for the treatment of melasma and related conditions. Dermatol. Surg., 1996, 22, 443-447.
[22]
Hermanns, J.F.; Petit, L.; Pierard-Franchimont, C.; Paquet, P.; Pierard, G.E. Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology, 2002, 204, 281-286.
[23]
Kameyama, K.; Sakai, C.; Kondoh, S.; Yonemoto, K.; Nishiyama, S.; Tagawa, M.; Murata, T.; Ohnuma, T.; Quigley, J.; Dorsky, A.; Bucks, D.; Blanock, K. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J. Am. Acad. Dermatol., 1996, 34, 29-33.
[24]
Nakajima, M.; Shinoda, I.; Fukuwatari, Y.; Hayasawa, H. Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity. Pigment Cell Res., 1998, 11, 12-17.
[25]
Yoshimura, K.; Tsukamoto, K.; Okazaki, M.; Virador, V.M.; Lei, T.C.; Suzuki, Y.; Uchida, G.; Kitano, Y.; Harii, K. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. Dermatol. Sci., 2001, 27, 68-75.
[26]
Ito, N.; Hirose, M.; Fukushima, S.; Tsuda, H.; Shirai, T.; Tatematsu, M. Studies on antioxidants: Their carcinogenic and modifying effects on chemical carcinogenesis. Food Chem. Toxicol., 1986, 24, 1071-1082.
[27]
Ashraf, Z.; Rafiq, M.; Seo, S.Y.; Kwon, K.S.; Babar, M.M.; Zaidi, N.S.S. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase. Eur. J. Med. Chem., 2015, 98, 203-211.
[28]
Ashraf, Z.; Rafiq, M.; Seo, S.Y.; Babar, M.M.; Zaidi, N.S.S. Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase. Bioorg. Med. Chem., 2015, 23, 5870-5880.
[29]
Seo, W.D.; Ryu, Y.B.; Curtis-Long, M.J.; Lee, C.W.; Ryu, H.W.; Jang, K.C.; Park, K.H. Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. Eur. J. Med. Chem., 2010, 45, 2010-2017.
[30]
Chiari, M.E.; Vera, D.M.A.; Palacios, S.M.; Carpinella, M.C. Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans. Bioorg. Med. Chem., 2011, 19, 3474-3482.
[31]
Rafiq, M.; Saleem, M.; Hanif, M.; Kang, S.K.; Seo, S.Y.; Lee, K.H. Synthesis, structural elucidation and bioevaluation of 4-amino-1,2,4 triazole-3-thione’s Schiff base derivatives. Arch. Pharm. Res., 2016, 39, 161-171.
[32]
Wang, Q.; Qiu, L.; Chen, X.R.; Song, K.K.; Shi, Y.; Chen, Q.X. Inhibitory effects of phloridzin dihydrate on the activity of mushroom (Agaricus bisporus) tyrosinase. Bioorg. Med. Chem., 2007, 15, 1568-1571.
[33]
Zhiyong, C.; Dachuan, C.; Dehai, M.; Qin, Y.; Yifeng, S.; Wenlong, P.; Yiqian, W.; Huacan, S.; Wei, Yi. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene (thio) barbiturates as novel tyrosinase inhibitors. Bioorg. Med. Chem., 2014, 22, 3279-3284.
[34]
Attri, P.; Venkatesu, P.; Kumar, A. Activity and stability of α-chymotrypsin in biocompatible ionic liquids: Enzyme refolding by triethyl ammonium acetate. Phys. Chem. Chem. Phys., 2011, 13, 2788-2796.
[35]
Gheibi, N.; Saboury, A.A.; Haghbeen, K.; Moosavi-Movahedi, A.A. Activity and structural changes of mushroom tyrosinase induced by n-alkyl sulfates. Colloids Surf. B Biointerfaces, 2005, 45, 104-107.
[36]
Ismaya, W.T.; Rozeboom, H.J.; Weijn, A.; Mes, J.J.; Fusetti, F.; Wichers, H.J.; Dijkstra, B.W. Crystal structure of Agaricus bisporus mushroom tyrosinase: Identity of the tetramer subunits and interaction with tropolone. Biochem., 2011, 50, 5477-5479.
[37]
Schrödinger, Release. 2016-4: Protein Preparation Wizard; Schrödinger: New York, 2016.
[38]
Schrödinger, Release. 2016-4: Ligand Docking protocol; Glide; Schrödinger: New York, 2016.
[39]
Kumar, N.; Attri, P.; Yadav, D.K.; Choi, J.; Choi, E.H.; Uhm, H.S. Induced apoptosis in melanocytes cancer cell and oxidation in biomolecules through deuterium oxide generated from atmospheric pressure non-thermal plasma jet. Sci. Rep., 2014, 4, 7589.
[40]
Park, J.H.; Kumar, N.; Park, D.H.; Yusupov, M.; Neyts, E.C.; Verlackt, C.C.; Bogaerts, A.; Kang, M.H.; Uhm, H.S.; Choi, E.H.; Attri, P. A comparative study for the inactivation of multidrug resistance bacteria using dielectric barrier discharge and nano-second pulsed plasma. Sci. Rep., 2015, 5, 13849.
[41]
Ryu, Y.H.; Kim, Y.H.; Lee, J.Y.; Shim, G.B.; Uhm, H.S.; Pazrk, G.; Choi, E.H. Effects of background fluid on the efficiency of inactivating yeast with non-thermal atmospheric pressure plasma. PLoS One, 2013, 8e66231
[42]
Sasaki, M.; Kizawa, K.; Igarashi, S.; Horikoshi, T.; Uchiwa, H.; Miyachi, Y. Suppression of melanogenesis by induction of endogenous intracellular metallothionein in human melanocytes. Exp. Dermatol., 2004, 13, 465-471.
[43]
Huang, H.C.; Hsieh, W.Y.; Niu, Y.L.; Chang, T.M. Inhibitory effects of adlay extract on melanin production and cellular oxygen stress in B16F10 melanoma cells. Int. J. Mol. Sci., 2014, 15, 16665-16679.
[44]
Kumar, N.; Attri, P.; Choi, E.H.; Uhm, H.S. Influence of water vapour with non-thermal plasma jet on the apoptosis of SK-BR-3 breast cancer cells. RSC Advances, 2015, 5, 14670-14677.
[45]
Westerfield, M. The Zebrafish Book. A Guide for the Laboratory
Use of Zebrafish (Danio rerio): Eugene, 2007.
[46]
Ali, A.; Ashraf, Z.; Kumar, N.; Rafiq, M.; Jabeen, F.; Park, J.H.; Choi, K.H.; Lee, S.H.; Seo, S.Y.; Choi, E.H.; Attri, P. Sci. Rep., 2016, 6, 21779-21799.
[47]
Bagherzadeh, K.; Shirgahi, T.F.; Sharifi, A.; Ganjali, M.R.; Saboury, A.A.; Amanlou, M.J. A new insight into mushroom tyrosinase inhibitors: Docking, pharmacophore-based virtual screening, and molecular modeling studies. Biomol. Struct. Dyn., 2015, 33, 487-501.
[48]
Ha, Y.M.; Park, Y.J.; Lee, J.Y.; Park, D.; Choi, Y.J.; Lee, E.K.; Kim, J.M.; Kim, J.A.; Park, J.Y.; Lee, H.J.; Moon, H.R.; Chung, H.Y. Design, synthesis and biological evaluation of 2-(substituted phenyl) thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors. Biochimie, 2012, 94, 533-540.
[49]
Quigley, I.K.; Parichy, D.M. Pigment pattern formation in zebrafish: A model for developmental genetics and the evolution of form. Microsc. Res. Tech., 2002, 58, 442-455.
[50]
Jeong, Y.M.; Oh, W.K.; Tran, T.L.; Kim, W.K.; Sung, S.H. Aglycone of Rh4 inhibits melanin synthesis in B16 melanoma cells: Possible involvement of the protein kinase: A pathway. Biosci. Biotechnol. Biochem., 2013, 77, 119-125.
[51]
Peng, H.Y.; Lin, C.C.; Wang, H.Y.; Shih, Y.; Chou, S.T. The melanogenesis alteration effects of Achillea millefolium l. Essential oil and linalyl acetate: Involvement of oxidative stress and the jnk and erk signaling pathways in melanoma cells. PLoS One, 2014, 9e95186
[52]
Funasaka, Y.; Komoto, M.; Ichihashi, M. Depigmenting effect of alpha-tocopheryl ferulate on normal human melanocytes. Pigment Cell Res., 2000, 13, 170-174.
[53]
Chakraborty, A.K.; Funasaka, Y.; Slominski, A.; Ermak, G.; Hwang, J.; Pawelek, J.M.; Ichihashi, M. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: Regulation by ultraviolet B. Acta. Mol. Cell Res., 1996, 1313, 130-138.
[54]
Chou, T.H.; Ding, H.Y.; Hung, W.J.; Liang, C.H. Antioxidative characteristics and inhibition of α‐melanocyte‐stimulating hormone‐stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare. Exp. Dermatol., 2010, 19, 742-750.
[55]
Yanase, H.; Ando, H.; Horikawa, M.; Watanabe, M.; Mori, T.; Matsuda, N. Possible involvement of ERK 1/2 in UVA-induced melanogenesis in cultured normal human epidermal melanocytes. Pigment Cell Res., 2001, 14, 103-109.
[56]
Barbazuk, W.B.; Korf, K.; Heyen, J.; Tate, S.; Wun, E.; Bedell, J.A.; McPherson, J.D.; Johnson, S.L. The syntenic relationship of the zebrafish and human genomes. Genome Res., 2000, 10, 1351-1358.
[57]
Tassabehji, M.; Newton, V.E.; Read, A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet., 1994, 8, 251-255.
[58]
Lister, J.A.; Robertson, C.P.; Lepage, T.; Johnson, S.L.; Raible, D.W. Nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development, 1999, 126, 3757-3767.
[59]
Chi, H.H.; Zhi, H.W.; Chang, S.L.; Govindasamy, A. Zebrafish: A complete animal model for in vivo drug discovery and development. Curr. Drug Metab., 2009, 10, 116-124.
[60]
Ulrich, R.; Friend, S.H. Toxicogenomics and drug discovery: Will new technologies help us produce better drugs? Nat. Rev. Drug Discov., 2002, 1, 84-88.
[61]
Llorens, O.; Perez, J.J.; Villar, H.O. Toward the design of chemical libraries for mass screening biased against mutagenic compounds. J. Med. Chem., 2001, 44, 2793-2804.
[62]
Pritchard, J.F.; Jurima-Romet, M.; Reimer, M.L.; Mortimer, E.; Rolfe, B.; Cayen, M.N. Making better drugs: Decision gates in nonclinical drug development. Nat. Rev. Drug Discov., 2003, 2, 542-553.
[63]
Spitsbergen, J.M.; Kent, M.L. The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol. Pathol., 2003, 31, 62-87.
[64]
Rubinstein, A.L. Zebrafish assays for drug toxicity screening. Expert Opin. Drug Metab. Toxicol., 2006, 2, 231-240.
[65]
Tae-Young, C.; Jin-Hwa, K.; Dong, H. Ko.; Cheol-Hee, K.; Jae-Sung, H.; Soomi, A.; Sun, Y.K.; Chang-Deok, K.; Jeung-Hoon, L.; Tae-Jin, Y. Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res., 2006, 20, 120-127.
[66]
Huang, H.C.; Chang, T.Y.; Chang, L.Z.; Wang, H.F.; Yih, K.H.; Hsieh, W.Y.; Chang, T.M. Inhibition of melanogenesis versus antioxidant properties of essential oil extracted from leaves of Vitex negundo linn and chemical composition analysis by GC-MS. Molecules, 2012, 17, 3902-3916.
66
9
1